CD3CD20MBS303BI…
IDR 10,000.00
mbs303 MBS 303 is a bispecific antibody targeting CD3CD20 being developed by Beijing Mabworks Biotech for the treatment of B cell non-Hodgkin lymphoma. The. MBS303, composed of a 2:1 bispecific antibody structure, binds to CD20 with two arms and CD3 molecule with one arm to increase affinity with tumor cells and decrease the off-target toxicity
mbs303, Find the best pricing for Yageo MBS303-B-AX-0RAA by comparing bulk discounts from 4 distributors. Octopart is the world's source for MBS303-B-AX-0RAA availability, pricing,.
Quantity: